Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi | Paris | Healthcare | Pharmaceuticals | EUR 123.95B | 14.3x | -0.58 | EUR 98.92 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.4% Upside | Upgrade to Pro+ | |
Ipsen | Paris | Healthcare | Pharmaceuticals | EUR 9.29B | 13.7x | 0.28 | EUR 113 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.2% Upside | Upgrade to Pro+ | |
Virbac | Paris | Healthcare | Pharmaceuticals | EUR 2.95B | 20.9x | 1.09 | EUR 352 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.1% Upside | Upgrade to Pro+ | |
Vetoquinol | Paris | Healthcare | Pharmaceuticals | EUR 935.95M | 19.9x | -1.03 | EUR 79.10 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25% Upside | Upgrade to Pro+ | |
Boiron | Paris | Healthcare | Pharmaceuticals | EUR 566.88M | 24x | -0.47 | EUR 32.65 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2% Upside | Upgrade to Pro+ | |
Medincell | Paris | Healthcare | Pharmaceuticals | EUR 440.39M | -17.2x | -0.57 | EUR 15.14 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 46.9% Upside | Upgrade to Pro+ | |
Euroapi | Paris | Healthcare | Pharmaceuticals | EUR 340.28M | -1.3x | 0 | EUR 3.74 | 4.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -16% Downside | Upgrade to Pro+ | |
DBV Technologies | Paris | Healthcare | Pharmaceuticals | EUR 74.07M | -0.9x | -0.07 | EUR 0.77 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AB Science | Paris | Healthcare | Pharmaceuticals | EUR 65.81M | -8.6x | -0.16 | EUR 1.01 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Berkem | Paris | Healthcare | Pharmaceuticals | EUR 54.02M | EUR 3.06 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 46.6% Upside | Upgrade to Pro+ | |||
Aelis Farma | Paris | Healthcare | Pharmaceuticals | EUR 47.39M | -8.1x | 0.38 | EUR 3.48 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Advicenne | Paris | Healthcare | Pharmaceuticals | EUR 23.58M | -2.5x | -0.09 | EUR 1.92 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nicox | Paris | Healthcare | Pharmaceuticals | EUR 16.85M | -0.7x | EUR 0.25 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
SMAIO | Paris | Healthcare | Pharmaceuticals | EUR 16.48M | -14.2x | -1 | EUR 3.18 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Valerio Therapeutics | Paris | Healthcare | Pharmaceuticals | EUR 12.50M | -0.6x | -0.02 | EUR 0.08 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pharnext | Paris | Healthcare | Pharmaceuticals | EUR 173.88 | -0x | EUR 0.001 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |